Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Phase	STARTED	Dravet Syndrome	315
Treatment Phase	STARTED	Lennox-Gastaut Syndrome	366
Treatment Phase	COMPLETED	Dravet Syndrome	170
Treatment Phase	COMPLETED	Lennox-Gastaut Syndrome	243
Treatment Phase	NOT COMPLETED	Dravet Syndrome	145
Treatment Phase	NOT COMPLETED	Lennox-Gastaut Syndrome	123
Taper Phase	STARTED	Dravet Syndrome	79
Taper Phase	STARTED	Lennox-Gastaut Syndrome	71
Taper Phase	COMPLETED	Dravet Syndrome	76
Taper Phase	COMPLETED	Lennox-Gastaut Syndrome	67
Taper Phase	NOT COMPLETED	Dravet Syndrome	3
Taper Phase	NOT COMPLETED	Lennox-Gastaut Syndrome	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02224573/flow